Copeptin in Outcome Prediction of an Acute Psychotic Episode (CoPsych)
Copeptin - A Biomarker to Improve Outcome Prediction in Patients With an Acute Psychotic Episode
Sponsor: University Hospital, Basel, Switzerland
This observational or N/A phase trial investigates Acute Psychotic Episode and Affective Disorder and is currently completed. University Hospital, Basel, Switzerland leads this study, which shows 12 recorded versions since 2017 — indicating substantial longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
▶ Show 7 earlier versions
-
Oct 2020 — Nov 2020 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Sep 2019 — Oct 2020 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Sep 2018 — Sep 2019 [monthly]
Recruiting
-
Jun 2018 — Sep 2018 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Sep 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
May 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital, Basel, Switzerland
For direct contact, visit the study record on ClinicalTrials.gov .